Day One Biopharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Day One Biopharmaceuticals generated cash of -$146,853,000, which is less than the previous year. Cash used in financing activities reached the amount of $163,997,000 last year. Net change in cash is therefore $145,522,000.
Cash Flow
| 2019 | -4.51M | 0 | 30.90M |
|---|---|---|---|
| 2020 | -13.48M | -92K | 29.97M |
| 2021 | -48.53M | -8M | 297.12M |
| 2022 | -109.87M | -255.07M | 165.90M |
| 2023 | -146.85M | 128.37M | 163.99M |
DAWN Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 85.26M | 284.30M | 43.72M | 27.33M | 942K |
Operating activities | |||||
Net income | -188.91M | -142.18M | -72.75M | -43.84M | -16.98M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 383K | 531K | 199K | 155K | 0 |
Stock-based compensation expense | 39.34M | 27.24M | 13.32M | 526K | 111K |
| Deferred income tax benefit | 39.34M | 27.24M | 13.32M | 526K | 111K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 2.31M | -1.48M | 1.54M | 132K | 14K |
Cash generated by operating activities | -146.85M | -109.87M | -48.53M | -13.48M | -4.51M |
Investing activities | |||||
Purchases Of Investments | -443.83M | -394.20M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -224K | -26K | -8M | -92K | 0 |
Acquisitions Net | 0 | 255.04K | 0 | 0 | 0 |
Cash generated by investing activities | 128.37M | -255.07M | -8M | -92K | 0 |
Financing activities | |||||
Common Stock Issued | 161.40M | 161.61M | 167.04M | 29.97M | 29.90M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 318K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 1M |
Cash used in financing activities | 163.99M | 165.90M | 297.12M | 29.97M | 30.90M |
Net Change In Cash | 145.52M | -199.04M | 240.58M | 16.39M | 26.39M |
Cash at end of period | 230.78M | 85.26M | 284.30M | 43.72M | 27.33M |
| Data source | Data source | Data source |